FDA Approves Senseonics’ Continuous Glucose Monitoring System
Senseonics announces the approval of its next-generation Eversense E3 CGM System by the U.S. FDA.
Senseonics announces the approval of its next-generation Eversense E3 CGM System by the U.S. FDA.
Through a new partnership, Hill-Rom and the University of Pennsylvania seek to develop new “smart” technology to address challenges in hospital rooms.
Senseonics announces the approval of its next-generation Eversense E3 CGM System by the U.S. FDA.